Recently the stock price of pharmaceutical company Divi's Labs fell by over 30% in last three sessions and hits two-years low, after USFDA found compliance issues against the company's Chippada Village unit in Visakhapatnam, Andhra Pradesh. Just like Sun Pharma and Divi's Labs, even Mumbai-based Aurobindo Pharma came under the scanner of USFDA once in February for company's unit VII in Mahaboobnagar district in Telangana and again in December this year for the unit I in Hyderabad. On December 16, the company's shares hit nine-month low after it was named in a lawsuit alleging it colluded with other drug makers to fix prices of two commonly used drugs in the US. On a brighter side, Biocon has performed well with its stock up 76.4% in CY2016. The company's share price shot up to Rs 916.45 on December 27, 2016, from Rs 518.05 on December 31, last year.